Linoleic Acid

Linoleic acid is a polyunsaturated omega-6 fatty acid that Ray Peat identified as a primary driver of degenerative disease, arguing that its designation as an “essential” nutrient was a marketing campaign built on flawed science. 2 Peat traced the origin of the essential fatty acid concept to the Burrs’ experiments in 1929, noting that the Burrs themselves later demonstrated that adding linoleic acid back to a deficient diet suppressed metabolism by about 50%. 2 He emphasized that a human subject in the Burrs’ own lab lived for months on a diet devoid of linoleic, linolenic, and arachidonic acid, during which chronic conditions like migraines and hypertension disappeared. 1 Peat maintained that cells can be grown indefinitely in culture without any polyunsaturated fats, which he considered proof that they are not essential nutrients. 2

At a mechanistic level, Peat described linoleic acid as a systemic poison that disrupts thyroid function at every known level—synthesis, transport, and cellular response—with the degree of inhibition proportional to the number of double bonds. 5 He cited research from 1964 showing that the most advanced atherosclerotic lesions contained the highest concentrations of linoleic acid, and that its oxidation products accumulate in degenerating tissue. 3 Peat also connected linoleic acid to the formation of prostaglandins, which promote inflammation, and to the spontaneous oxidation of brain fats into isoprostanes and neuroprostanes that accompany Alzheimer’s disease. 2 He noted that the brain becomes increasingly polyunsaturated with age, and that the resulting prostaglandin activity contributes to tissue under-functioning. 7

Georgi Dinkov has extended Peat’s framework by documenting linoleic acid’s direct role in cancer progression. He highlighted a mechanism in which linoleic acid binds to and activates FABP5, an enzyme that facilitates PUFA uptake into cells and is highly correlated with poor prognosis in multiple cancers. 8 Dinkov argued that linoleic acid functions as a dietary carcinogen not only through its role as a precursor to inflammatory prostaglandins and leukotrienes, but also through its own endocrine effects, which he described as mimicking estrogen—a known human carcinogen. 2 He noted that average American consumption exceeds 50 grams of linoleic acid daily, roughly 25 times the amount needed to satisfy any theoretical requirement, and that the rising curve of chronic disease closely matches the historical increase in omega-6 intake. 2

Peat and Dinkov both rejected the industry pivot from omega-6 to omega-3 fish oils as a remedy. Peat explained that fish oil’s apparent anti-inflammatory effect is actually a temporary immune suppression, while in the long run it increases inflammatory and degenerative processes, as demonstrated by the yellow fat disease and brain degeneration observed in animals fed fish waste. 2 Dinkov added that genetically modified soy oil with low linoleic acid but high oleic acid still caused fatty liver disease, a pathology shared with olive oil, while coconut oil and fructose caused neither diabetes nor liver damage. 11 Peat summarized the historical arc by stating that linoleic acid was ultimately recognized as essential for cancer, but not for nutrition. 10